Literature DB >> 2922001

Flow cytometric analysis of X-ray sensitivity in ataxia telangiectasia.

N S Rudolph1, S A Latt.   

Abstract

Flow cytometric analysis of 5-bromodeoxyuridine (BrdU) incorporation during DNA synthesis was used to characterize the effects of X-rays on cell-cycle kinetics in the DNA-repair deficiency disease ataxia telangiectasia (AT). Cultured fibroblasts from homozygotes (at/at), heterozygotes (at/+) and normal controls (+/+) were either: (1) irradiated, cultured, then pulsed with BrdU and harvested, or (2) pulsed with BrdU, irradiated, cultured and then harvested. Cells were then fixed and stained with both a fluoresceinated monoclonal antibody against BrdU to identify S-phase cells and with propidium diiodide to measure total DNA content. Irradiation of +/+ and at/+ cells induced a similar, transient G2/M arrest detectable within 8 h, which subsequently delayed by 6-8 h the passage of cells into G1 and depleted early S phase. In contrast, at/at cells failed to arrest in G2/M phase and entered the next cell cycle without pausing to repair radiation-induced damage. X-Rays also blocked entry of +/+ G1 cells into S phase, subsequently reducing the total S-phase population. This effect was not observed in at/at cells. These cell-cycle responses to radiation may be of diagnostic use and ultimately may help explain the basic defect in AT.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2922001     DOI: 10.1016/0027-5107(89)90104-8

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  13 in total

1.  Functional complementation of ataxia-telangiectasia group D (AT-D) cells by microcell-mediated chromosome transfer and mapping of the AT-D locus to the region 11q22-23.

Authors:  C Lambert; R A Schultz; M Smith; C Wagner-McPherson; L D McDaniel; T Donlon; E J Stanbridge; E C Friedberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

2.  Distinct roles of yeast MEC and RAD checkpoint genes in transcriptional induction after DNA damage and implications for function.

Authors:  G L Kiser; T A Weinert
Journal:  Mol Biol Cell       Date:  1996-05       Impact factor: 4.138

3.  The Saccharomyces cerevisiae RAD9 checkpoint reduces the DNA damage-associated stimulation of directed translocations.

Authors:  M Fasullo; T Bennett; P AhChing; J Koudelik
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

Review 4.  Regulation of the cell cycle following DNA damage in normal and Ataxia telangiectasia cells.

Authors:  H D Lohrer
Journal:  Experientia       Date:  1996-04-15

Review 5.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part III. Proliferation in normal, injured and diseased tissue, growth factors, differentiation, DNA replication sites and in situ hybridization.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1996-08

Review 6.  Ataxia-telangiectasia and the ATM gene: linking neurodegeneration, immunodeficiency, and cancer to cell cycle checkpoints.

Authors:  Y Shiloh; G Rotman
Journal:  J Clin Immunol       Date:  1996-09       Impact factor: 8.317

7.  The ATM homologue MEC1 is required for phosphorylation of replication protein A in yeast.

Authors:  G S Brush; D M Morrow; P Hieter; T J Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

8.  Occurrence of TRGV-BJ hybrid gene in SV40-transformed fibroblast cell lines.

Authors:  L P G D'Arce; C L Bassi; A L Fachin; G A S Passos; E T Sakamoto-Hojo
Journal:  Genetica       Date:  2009-01-14       Impact factor: 1.082

9.  Characterization of G1 checkpoint control in the yeast Saccharomyces cerevisiae following exposure to DNA-damaging agents.

Authors:  W Siede; A S Friedberg; I Dianova; E C Friedberg
Journal:  Genetics       Date:  1994-10       Impact factor: 4.562

Review 10.  Cell cycle regulation in response to DNA damage in mammalian cells: a historical perspective.

Authors:  J P Murnane
Journal:  Cancer Metastasis Rev       Date:  1995-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.